Pages that link to "Q33959792"
Jump to navigation
Jump to search
The following pages link to Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity (Q33959792):
Displaying 50 items.
- Cdk6-dependent regulation of G(1) length controls adult neurogenesis (Q24293050) (← links)
- Cdc2: a monopotent or pluripotent CDK? (Q24300976) (← links)
- Inhibitor of cyclin-dependent kinase (CDK) interacting with cyclin A1 (INCA1) regulates proliferation and is repressed by oncogenic signaling (Q24301328) (← links)
- Cell cycle, CDKs and cancer: a changing paradigm (Q24314465) (← links)
- Cyclin C/cdk3 promotes Rb-dependent G0 exit (Q24336871) (← links)
- Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice (Q24545945) (← links)
- Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization (Q24674862) (← links)
- An oncologist׳s friend: How Xenopus contributes to cancer research (Q26849774) (← links)
- D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cells (Q27690967) (← links)
- Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia. (Q27851940) (← links)
- Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers (Q28069910) (← links)
- Targeting CDK4 and CDK6: From Discovery to Therapy (Q28082912) (← links)
- Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo (Q28202769) (← links)
- Accumulation of high levels of the p53 and p130 growth-suppressing proteins in cell lines stably over-expressing cyclin-dependent kinase 6 (cdk6) (Q28203240) (← links)
- Cyclin D as a therapeutic target in cancer (Q28242623) (← links)
- Cell cycle kinases as therapeutic targets for cancer (Q28250447) (← links)
- p16INK4a induces an age-dependent decline in islet regenerative potential (Q28262230) (← links)
- Expression of cyclin D1 and CDK4 causes hypertrophic growth of cardiomyocytes in culture: a possible implication for cardiac hypertrophy (Q28576549) (← links)
- Genetic rescue of Cdk4 null mice restores pancreatic beta-cell proliferation but not homeostatic cell number (Q28584893) (← links)
- Failure to proliferate and mitotic arrest of CDK11(p110/p58)-null mutant mice at the blastocyst stage of embryonic cell development (Q28585216) (← links)
- Global growth deficiencies in mice lacking the ribosomal protein HIP/RPL29 (Q28586543) (← links)
- RB regulates pancreas development by stabilizing Pdx1 (Q28592305) (← links)
- Mutation in mouse hei10, an e3 ubiquitin ligase, disrupts meiotic crossing over (Q28594464) (← links)
- Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15 (Q28834132) (← links)
- A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants (Q29547210) (← links)
- Nanodiamonds as novel nanomaterials for biomedical applications: drug delivery and imaging systems (Q30459082) (← links)
- The HECT E3 ligase Smurf2 is required for Mad2-dependent spindle assembly checkpoint (Q30484127) (← links)
- The Cdk4-E2f1 pathway regulates early pancreas development by targeting Pdx1+ progenitors and Ngn3+ endocrine precursors (Q30499855) (← links)
- Signalling responses linked to betulinic acid-induced apoptosis are antagonized by MEK inhibitor U0126 in adherent or 3D spheroid melanoma irrespective of p53 status (Q33223047) (← links)
- Cdk4 regulates recruitment of quiescent beta-cells and ductal epithelial progenitors to reconstitute beta-cell mass (Q33525054) (← links)
- Normal proliferation and tumorigenesis but impaired pancreatic function in mice lacking the cell cycle regulator sei1. (Q33525540) (← links)
- Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency (Q33545232) (← links)
- Absence of p53-dependent apoptosis combined with nonhomologous end-joining deficiency leads to a severe diabetic phenotype in mice (Q33556469) (← links)
- Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner (Q33724405) (← links)
- p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation (Q33743648) (← links)
- Cyclin D2 is essential for the compensatory beta-cell hyperplastic response to insulin resistance in rodents (Q33750760) (← links)
- Mangiferin facilitates islet regeneration and β-cell proliferation through upregulation of cell cycle and β-cell regeneration regulators (Q33755933) (← links)
- Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth (Q33758338) (← links)
- Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis (Q33810358) (← links)
- CDK-mediated regulation of cell functions via c-Jun phosphorylation and AP-1 activation (Q33894814) (← links)
- Cell-cycle inhibitors: three families united by a common cause (Q33895611) (← links)
- To cycle or not to cycle: a critical decision in cancer. (Q33957955) (← links)
- Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis (Q33966276) (← links)
- Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d) (Q33968117) (← links)
- Expression of arf tumor suppressor in spermatogonia facilitates meiotic progression in male germ cells (Q33979535) (← links)
- Genetic evidence for the interactions of cyclin D1 and p27(Kip1) in mice (Q34011646) (← links)
- MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2. (Q34054054) (← links)
- Glucose infusion in mice: a new model to induce beta-cell replication (Q34066982) (← links)
- Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle (Q34076834) (← links)
- Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. (Q34078091) (← links)